Absar, Muhammad; Akhtar, Tanveer; Jameel, Abid; Mahmood, Amer; Ullah, Anhar; Aleem, Aamer; Qureshi, Kulsoom; Rehman, Noor; Iqbal, Zafar
(Karachi:Pakistan Journal of Pharmaceutical Sciences, University of Karachi., 2020-01-15)
The outcome of chronic myeloid leukemia has been greatly improved by the use of Imatinib (IM), a selective
BCR/ABL kinase inhibitor. The aim of present study was to report long term follow-up & outcome of IM-treated CML ...